PTC Therapeutics Inc (NAS:PTCT)
$ 44.16 -0.46 (-1.03%) Market Cap: 3.41 Bil Enterprise Value: 2.83 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

Q4 2018 PTC Therapeutics Inc Earnings Call Transcript

Feb 28, 2019 / 09:30PM GMT
Release Date Price: $34.54 (-1.96%)
Operator

Good day, ladies and gentlemen, and welcome to the PTC Therapeutics Fourth Quarter and Full Year 2018 Financial Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded.

It is now my pleasure to introduce Head of Investor Relations, Ms. Emily Hill. Please go ahead.

Emily Hill
PTC Therapeutics, Inc. - Executive Director of IR

Hello, good afternoon, and thank you for joining us to discuss our 2018 fourth quarter and full year corporate updates and financial results. Joining me on today's call is our CEO, Stuart Peltz; our Chief Operating Officer, Marcio Souza; and our Principal Financial Officer, Christine Utter.

Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Please take a moment to review our slides from our current corporate presentation, which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements as any and such risks can materially and adversely affect our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot